Markets
Stocks
Funds
Sectors
Tools
Treasury & Bonds
Overview
Market News
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
My Portfolio
Zomedica Pharmaceuticals Corp
(NY:
ZOM
)
0.6800
USD
+0.0275 (+4.21%)
Streaming Delayed Price
/ Updated:
8:00 PM EST, Feb 15, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
45,200
Open
0.6500
Bid (Size)
0.6750 (1)
Ask (Size)
1.070 (1)
Prev. Close
0.6525
Today's Range
0.6500 - 0.7300
52wk Range
0.6500 - 2.980
Shares Outstanding
94,511,209
Dividend Yield
N/A
Performance
YTD
-45.60%
-45.60%
1 Month
-41.88%
-41.88%
3 Month
-57.23%
-57.23%
6 Month
-68.37%
-68.37%
1 Year
-69.78%
-69.78%
Top News
More News
Zomedica Appoints Dr. Bonnie Bragdon as Vice President of Veterinary Affairs
January 15, 2019
Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced the appointment of Bonnie Bragdon, DVM, MS, as Vice President of...
Read More
from
GlobeNewswire News Releases
Zomedica Announces $4.28 Million Private Placement Closing and Corporate Update
January 14, 2019
Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today announced the completion of its previously...
Read More
from
GlobeNewswire News Releases
More News
Read More
Zomedica Provides Update on Pipeline Development and Announces At-The-Market Offering Program
December 20, 2018
from
GlobeNewswire News Releases
IncellDx and Zomedica Sign Diagnostic CTC Assay Development Agreement for Canine Cancer
December 19, 2018
from
PR Newswire
Zomedica Signs Exclusive Agreement with Qorvo Biotechnologies for Global Veterinary Rights to Diagnostic Point-of-Care Platform
November 27, 2018
from
GlobeNewswire News Releases
Zomedica Announces $10 Million Private Offering of Common Shares
November 27, 2018
from
GlobeNewswire News Releases
Analysis: Positioning to Benefit within Dominion Energy Midstream Partners, LP, Blue Capital Reinsurance, CRH Medical, Friedman Industries, CM Finance, and Zomedica Pharmaceuticals — Research Highligh
November 26, 2018
from
GlobeNewswire News Releases
Zomedica Pharmaceuticals Corp. Announces Third Quarter 2018 Financial Results
November 13, 2018
from
GlobeNewswire News Releases
Zomedica Pharmaceuticals Corp. to Present at Jefferies 2018 London Healthcare Conference and LD Micro Main Event XI
November 12, 2018
from
GlobeNewswire News Releases
SeeThruEquity Issues Update on Zomedica Pharmaceuticals Corp.
October 16, 2018
from
ACCESSWIRE
Zomedica Pharmaceuticals Corp. to Present at LD Micro NYC Summit and Cantor 2018 Global Healthcare Conference
September 18, 2018
from
GlobeNewswire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.